The strategies for treating PRMS include:
- Modifying the disease course
The interferon beta medications (Avonex®, Betaseron® and Rebif® and Tysabri® (natalizumab) are approved by the FDA for use in relapsing forms of MS, which includes people with progressive-relapsing MS who have occasional relapses. If the person’s physician feels that the interferon medication does not do an adequate job of controlling disease activity, he or she will likely recommend changing to Tysabri (natalizumab) or Novantrone® (mitoxantrone).
- Managing symptoms
Regardless of the course of MS a person is experiencing, proactive symptom management is essential to maintaining comfort and productivity, and enhancing quality of life.
- Enhancing mobility and promoting safety and independence
Rehabilitation specialists have an important role, from the time of diagnosis onward, in helping people function optimally in spite of their MS
- Promoting overall health and wellness
Health and wellness can be achieved even in the presence of a chronic illness or disability.
- Promoting emotional well-being and quality of life